DNLI Stock-Based Compensation
Denali Therapeutics Inc · Stock-Based Compensation
DNLI Stock-Based Compensation
Latest reported$69.95Mperiod ending
DNLI Stock-Based Comp ($479.00K → $69.95M)
Annual stock-based compensation
High-resolution chart · PNG
DNLI stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 99,633,000 | |
| 102,878,000 | |
| 108,102,000 | |
| 99,847,000 | |
| 85,247,000 | |
| 50,351,000 | |
| 38,378,000 | |
| 18,791,000 | |
| 4,409,000 | |
| 2,951,000 | |
| 479,000 |